GHK-CU
❄️Lyophilized powder
Größe:
Rabatt pro Menge
| Menge | Rabatt | Preis pro Einheit |
|---|---|---|
| 5 - 10 | 10% | €26.99 |
| 11 - 20 | 15% | €25.49 |
| 21+ | 20% | €23.99 |
Strenge Tests durch unabhängige Labore
Jede Charge unserer Forschungschemikalien und Peptide wird von einem unabhängigen Labor auf Reinheit und Identität geprüft.
Gesamt: €29.99
For laboratory research use only by qualified professionals. Not for human or veterinary use. Not for ingestion, injection, topical application, diagnostic, therapeutic, prophylactic or cosmetic use.
GHK-CU is supplied as a catalogued research material in 50mg and 100mg. It is intended only for controlled analytical, biochemical and non-clinical laboratory workflows. The catalogue amount identifies the nominal vial presentation; it is not a dose or a use instruction.
GHK-Cu is not a single self-defining solid-form name. Authoritative public records represent materially different peptide:copper ratios and counter-ion forms. No one formula, mass, CAS number or PubChem CID should be assigned to these catalogue variants until the specification and matching CoA establish the actual complex [1–3].
Product identity
Identity must be assigned to the exact batch rather than to a marketed name alone. Sequence, terminal modifications, conjugation, salt or counter-ion, hydration state and excipients may change the applicable mass and registry identifiers. The batch CoA and SDS take precedence over literature identifiers shown below.
Chemical properties and registry information
| Property | Value |
|---|---|
| Name and synonyms | GHK-Cu; copper–Gly-His-Lys complex; copper tripeptide-1, when the exact complex matches |
| Material category | Copper(II) coordination complex of a tripeptide; exact stoichiometry and counter-ion unconfirmed |
| Sequence or structural definition | Gly–His–Lys coordinated to Cu(II); the catalogue name does not establish a 1:1 or 2:1 peptide:copper complex |
| Molecular formula | Not assigned to the batch; public records include C14H23CuN6O4+ (1:1), C28H48CuN12O8 (2:1) and distinct acetate forms |
| Average molecular mass | Not assigned to the batch; reference representations are approximately 402.92 g/mol (1:1), 744.3 g/mol (2:1) and 461.96 g/mol for one acetate record |
| CAS Registry Number | Not assigned to the batch; CAS 89030-95-5 and 300801-03-0 map to different public complex representations |
| PubChem CID | Not assigned to the batch; relevant records include CID 71587328 (1:1), CID 133697840 (2:1) and CID 162343861 (acetate) |
| Structural features | Cu(II) coordination changes charge, stoichiometry and mass; peptide:copper ratio, oxidation state, counter-ion, hydration and free copper require batch confirmation |
| Physical form | Catalogue vial; the exact physical state, salt or counter-ion and excipients are batch-specific and must be verified in the CoA and SDS. |
| Catalogue presentations | 50mg and 100mg |
| Batch identity and quality documentation | Lot-specific identity and available analytical reports must be verified against the CoA entry associated with the exact product size and batch. |
| Intended use | Analytical, biochemical and non-clinical laboratory research only; all human and veterinary uses are excluded. |
Where an identifier is qualified or omitted, no unambiguous exact-form public assignment has been confirmed. Do not transfer an identifier from a related analogue, salt, conjugate or formulation.
Research context and evidence status
What the literature supports
The literature supports copper-binding and coordination research involving the Gly-His-Lys tripeptide. Those chemical observations can guide identity and analytical-method work, provided the complex stoichiometry and form are defined [1–4].
Evidence limitations
Component chemistry and studies of separately manufactured topical or preclinical materials do not establish systemic safety, efficacy, dosage, administration, cosmetic suitability, or equivalence for these catalogue vials. Copper content and free copper are batch attributes, not consequences of the product name [1–4].
No authorised systemic medicinal-product status is inferred. The batch documentation should separately verify peptide identity and content, total copper, Cu:GHK molar ratio, free copper, counter-ion and relevant elemental impurities.
| Important | Research-use labeling does not itself determine the substance-specific legal status. The purchaser is responsible for confirming institutional authorization, local restrictions and lawful procurement, possession, import, export, storage and disposal. |
Technical comparison
The comparison below is limited to structural and analytical distinctions. It does not compare clinical performance or recommend a use.
| Aspect | This catalogue material | Comparator |
|---|---|---|
| Identity | Catalogue GHK-CU with unconfirmed peptide:copper stoichiometry and counter-ion | A defined 1:1 or 2:1 GHK–Cu reference complex with specified counter-ion |
| Structural distinction | The catalogue name alone does not define coordination ratio, charge or solid form | Stoichiometry, charge and form are explicitly assigned |
| Analytical implication | Requires orthogonal peptide identity, copper assay, Cu:GHK ratio, free-copper and counter-ion testing | Reference mass and registry identifiers apply only to the matching defined complex |
| What is not implied | No conclusion about human or veterinary safety, efficacy, dosage, route, duration or interchangeability. | No conclusion about human or veterinary safety, efficacy, dosage, route, duration or interchangeability. |
Quality and batch documentation
Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.
Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.
Laboratory handling and storage
Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.
This page intentionally provides no reconstitution, administration or dosing instructions. Laboratory preparation, analytical method selection, risk assessment, personal protective equipment and waste disposal must be defined by the qualified institution and the applicable SDS.
Regulatory and legal status
This catalogue material is not offered as a medicine, medical device, in-vitro diagnostic, food, dietary supplement, cosmetic or veterinary product. It is not intended to diagnose, treat, cure, mitigate or prevent any disease or condition.
A research designation does not override medicinal-product, controlled-substance, chemical, customs or other substance-specific rules. Availability may be restricted by jurisdiction and by the purchaser's verified professional or institutional status.
Sources and references
References document identity and research context only. They do not constitute instructions for use or evidence that this catalogue batch is suitable for any human or veterinary purpose.
- [1] PubChem. 1:1 copper–tripeptide/prezatide-copper representation, CID 71587328.
- [2] PubChem. 2:1 GHK:copper representation, CID 133697840.
- [3] PubChem. Distinct GHK-Cu acetate representation, CID 162343861.
- [4] Pickart et al. Copper-binding properties of the Gly-His-Lys tripeptide (1980).
Frequently Asked Questions
What is this material intended for?
Controlled laboratory research by qualified professionals, including substantiated analytical, biochemical or non-clinical workflows. It is not intended for personal use.
Is the amount shown on the vial a dosage?
No. It is a nominal catalogue presentation used to identify the product variant. It is not a dose, concentration, administration schedule or preparation instruction.
Do the CAS number and PubChem CID apply to every batch form?
Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.
What does an analytical purity result mean?
It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.
How should the material be stored and handled?
Follow the exact label, batch CoA and SDS, together with the institution's risk assessment. This page does not provide reconstitution or administration guidance.
May this material be used in humans or animals?
No. Human and veterinary use, including ingestion, injection, topical application, diagnosis, treatment, prevention and cosmetic use, is expressly excluded.
RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE. THE PRODUCT NAME, VIAL AMOUNT AND LITERATURE REFERENCES MUST NOT BE INTERPRETED AS A DOSAGE, ADMINISTRATION INSTRUCTION OR MEDICAL CLAIM.
LABORATORY RESEARCH MATERIAL — FOR QUALIFIED PROFESSIONAL USE ONLY
For analytical, biochemical or non-clinical laboratory research only. Not for human or veterinary use. Not for ingestion, injection, topical application, inhalation, diagnostic, therapeutic, prophylactic or cosmetic use.
Mandatory conditions:
- Restricted to qualified professionals acting for verified laboratories, universities, companies or other research institutions.
- The product name and nominal catalogue presentation are identifiers; they are not a dose, concentration, preparation protocol, ingestion instruction or administration instruction.
- Before laboratory work, verify the exact material identity, sequence or structure, physical form, fill, salt or counter-ion, lot number and matching CoA and SDS.
- Storage, handling, PPE, exposure response and disposal must follow the exact label, batch documentation, SDS and an institution-approved risk assessment.
- The purchaser is responsible for institutional authorization and for jurisdiction-specific rules governing procurement, import, export, possession, storage and disposal.
- Keep secured, correctly identified and inaccessible to children and all unauthorized persons.